Integra Lifesciences released its Q2 2024 results this week.
Organic growth reconciliation figures show that Wound Reconstruction and Care sales within the Tissue Technologies division fell from US$ 192.1 m for Q2 YTD 2024 to US$ 168.6 m in Q2 YTD 2024.
https://investor.integralife.com/events-and-presentations
- Forums
- ASX - By Stock
- PNV
- PNV - Banter and General Comments
PNV - Banter and General Comments, page-12184
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.33 |
Change
0.030(1.30%) |
Mkt cap ! $1.609B |
Open | High | Low | Value | Volume |
$2.29 | $2.34 | $2.27 | $2.949M | 1.276M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 19139 | $2.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.34 | 14111 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2512 | 2.300 |
3 | 10062 | 2.290 |
1 | 2062 | 2.280 |
2 | 6562 | 2.270 |
3 | 24835 | 2.260 |
Price($) | Vol. | No. |
---|---|---|
2.350 | 1900 | 1 |
2.360 | 2062 | 1 |
2.370 | 5198 | 2 |
2.380 | 12335 | 3 |
2.390 | 21545 | 4 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |